Lipofectamine-Mediated CRISPR-Cas9 Delivery Targeting the mecA Gene in Methicillin-Resistant Staphylococcus aureus: A Novel Approach to Reverse Antibiotic Resistance. WAJHN [Internet]. 2026 Jun. 30 [cited 2026 Jul. 21];2(2):27-35. Available from: https://wajhn.com/index.php/journal/article/view/77